Zephyr AI translates fragmented clinical and biological information into actionable insights to advance therapeutic development and diagnostics.
What it is
Zephyr AI is a precision medicine platform that combines multi-modal models, enterprise-scale real-world data, and curated oncology cohorts to support drug discovery, clinical validation, and diagnostic innovation.
Key features
- AIM Suite provides modular, interpretable machine learning tools for predicting treatment response.
- Nexus transforms electronic health records, claims, genomics, and pathology data into intelligence for over 90 million patients.
- Deep oncology data access via Aster Insights and the ORIEN Total Cancer Care study covering over 400,000 consented patients.
- Enterprise-grade infrastructure maintaining SOC 2 and HIPAA compliance for secure data handling.
- Companion diagnostics co-development for biopharma and diagnostic partners.
- mRNA expression reconstruction from DNA-based tests and minimal clinical data.
Who it's for
Biopharmaceutical companies, clinical researchers, and diagnostics developers looking to optimize patient selection, de-risk therapeutic development, and accelerate clinical translation.
Pricing
Check the official website for current pricing.
Use cases
- Predict treatment response using clinical data
- Reconstruct mRNA expression from DNA-based tests
- Define patient populations for clinical trials
Categories:
Similar to Zephyr AI
More Zephyr AI alternatives
Immunai
AnalyticsMap immune systems for drug discovery
Immunai maps the immune system at single-cell resolution using machine learning to power therapeutic development and clinical trial optimization.
